While our quantitative proteomic analyses identified that CTPS1 is approximately four times more abundant than CTPS2 in primary human B cells undergoing EBV-mediated growth transformation (28), EBV-infected lymphomas may compensate for CTPS1 deficiency by increasing CTPS2 levels and/or activity in vivo. This evidence concerns the gene CTPS1 and lymphoma.